Literature DB >> 32549960

Bone Loss Following Cementless Hemiarthroplasty for the Treatment of Femoral Neck Fracture.

Mert Murat1, Cenk Ermutlu2, Ethem Ayhan Unkar3, Sertaç Topalhafızoglu4, Ahmet Şenel4, Yusuf Öztürkmen4.   

Abstract

BACKGROUND: With the advances in medicine, an increasing number of the ageing population are a public health concern in terms of age-related complications. Among them, displaced neck fractures often require surgical intervention or arthroplasty to achieve the mobilization of the elderly and good life quality. The aim of the study is to monitor the changes in bone mineral density (BMD) around the femoral stem and the effects on functional outcomes in patients treated with cementless hemiarthroplasty following femoral neck fracture.
MATERIALS AND METHODS: Seventy-one patients aged 70 years or older who were treated with cementless hemiarthroplasty for a displaced femoral neck fracture were prospectively followed for 2 years. The percent change in the periprosthetic BMD in each Gruen zone was compared to the baseline using dual-energy X-ray absorptiometry (DEXA). Demographic factors [age, body mass index (BMI), and sex] that could possibly influence BMD and the clinical outcome were evaluated.
RESULTS: Fifty-one patients were available for the final follow-up. The mean age was 76.5 (range 70-89) years. The mean BMI was 28.9 (range 22.7-37.2). The mean Harris hip score at the final follow-up was 84.3 (range 72-93). There was a significant decrease in BMD in all Gruen zones (p < 0.001), except in zone 3 (R3, p = 0.547). The reduction in BMD was highest in the calcar and the greater trochanter region. The femur diaphysis was relatively spared, with zone 3 showing no significant bone mineral loss. The age and BMI of the patients were not correlated with the postoperative change in BMD in any of the Gruen zones. The degree of reduction in bone density was not correlated with the clinical outcome.
CONCLUSIONS: Cementless hemiarthroplasty for the treatment of femoral neck fracture in elderly patients achieves a good clinical outcome despite significant bone loss around the femoral stem. The reduction in BMD is more pronounced in the metaphyseal region. © Indian Orthopaedics Association 2020.

Entities:  

Keywords:  Bone loss; Clinical outcome; DEXA; Elderly; Gruen; Periprosthetic fracture

Year:  2020        PMID: 32549960      PMCID: PMC7270220          DOI: 10.1007/s43465-019-00009-1

Source DB:  PubMed          Journal:  Indian J Orthop        ISSN: 0019-5413            Impact factor:   1.251


  26 in total

1.  Larger femoral periprosthetic bone mineral density decrease following total hip arthroplasty for femoral neck fracture than for osteoarthritis: a prospective, observational cohort study.

Authors:  Tobias Mann; Thomas Eisler; Henrik Bodén; Olle Muren; André Stark; Mats Salemyr; Olof Sköldenberg
Journal:  J Orthop Res       Date:  2015-02-08       Impact factor: 3.494

2.  Bone loss following tibial osteotomy: a model for evaluating post-traumatic osteopenia.

Authors:  M K Karlsson; P O Josefsson; A Nordkvist; K Akesson; E Seeman; K J Obrant
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

Review 3.  Periprosthetic fractures: epidemiology and current treatment.

Authors:  Antonio Capone; Stefano Congia; Roberto Civinini; Giuseppe Marongiu
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

4.  Perioperative Periprosthetic Femur Fractures are Strongly Correlated With Fixation Method: an Analysis From the American Joint Replacement Registry.

Authors:  Bryan D Springer; Caryn D Etkin; Peter B Shores; Terence J Gioe; David G Lewallen; Kevin J Bozic
Journal:  J Arthroplasty       Date:  2019-02-10       Impact factor: 4.757

5.  Operative management of displaced femoral neck fractures in elderly patients. An international survey.

Authors:  Mohit Bhandari; P J Devereaux; Paul Tornetta; Marc F Swiontkowski; Daniel J Berry; George Haidukewych; Emil H Schemitsch; Beate P Hanson; Kenneth Koval; Douglas Dirschl; Pamela Leece; Marius Keel; Brad Petrisor; Martin Heetveld; Gordon H Guyatt
Journal:  J Bone Joint Surg Am       Date:  2005-09       Impact factor: 5.284

6.  Periprosthetic bone loss following hemiarthroplasty: a comparison between cemented and cementless hip prosthesis.

Authors:  Dinko Vidovic; Aljosa Matejcic; Marija Punda; Mihovil Ivica; Mladen Tomljenovic; Miroslav Bekavac-Beslin; August Mijic; Bore Bakota
Journal:  Injury       Date:  2013-09       Impact factor: 2.586

Review 7.  Bisphosphonates: mechanism of action and role in clinical practice.

Authors:  Matthew T Drake; Bart L Clarke; Suneep Khosla
Journal:  Mayo Clin Proc       Date:  2008-09       Impact factor: 7.616

Review 8.  Total hip arthroplasty versus hemiarthroplasty for displaced femoral neck fractures in the healthy elderly: a meta-analysis and systematic review of randomized trials.

Authors:  Paul T P W Burgers; Arnoud R Van Geene; Michel P J Van den Bekerom; Esther M M Van Lieshout; Bastiaan Blom; Ilyas S Aleem; M Bhandari; Rudolf W Poolman
Journal:  Int Orthop       Date:  2012-05-24       Impact factor: 3.075

9.  Less periprosthetic bone loss following the anterolateral approach to the hip compared with the direct lateral approach.

Authors:  Terje O Ugland; Glenn Haugeberg; Svein Svenningsen; Stein H Ugland; Øystein H Berg; Are Hugo Pripp; Lars Nordsletten
Journal:  Acta Orthop       Date:  2017-10-17       Impact factor: 3.717

10.  Cementing does not increase the immediate postoperative risk of death after total hip arthroplasty or hemiarthroplasty: a hospital-based study of 10,677 patients.

Authors:  Elina Ekman; Inari Laaksonen; Kari Isotalo; Antti Liukas; Tero Vahlberg; Keijo Mäkelä
Journal:  Acta Orthop       Date:  2019-04-01       Impact factor: 3.717

View more
  1 in total

1.  Proximal Femur Responses to Sequential Therapy With Abaloparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis by 3D Modeling of Hip Dual-Energy X-Ray Absorptiometry (DXA).

Authors:  Renaud Winzenrieth; Paul Kostenuik; John Boxberger; Yamei Wang; Ludovic Humbert
Journal:  JBMR Plus       Date:  2022-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.